Why I'm Not Arbing The Fresenius / Akorn Deal | Latest News RSS feed

Why I'm Not Arbing The Fresenius / Akorn Deal - Latest News


Why I'm Not Arbing The Fresenius / Akorn Deal

I am not interested in risk-arbing this deal at the current risk/reward profile (6.25% in 1 year). The deal continues to make sense from a strategic perspective for Fresenius, but I think Akorn has si... read more

Corruption Currents: Trump Asserts ‘Absolute Immunity’ in Emoluments Lawsuit

(AM ... if she is not indicted on charges of misusing government funds. (Haaretz) Court documents made public this week show Germany-based healthcare company Fresenius Medical Care & Co. said it found ... read more

Akorn accuses Fresenius of nixing $4.3B deal over buyer's remorse

(Bloomberg) — Fresenius ... Akorn's future, its lawyers said in the lawsuit. Fresenius spokesman Matthias Link said the company walked away from the deal because of because of the data integrity probl... read more

Looking for another news?


Fresenius says Akorn deal closure could take until next year (FRE, AKRX, FME)

FRANKFURT, Nov 22 (Reuters) - German healthcare group Fresenius SE said the planned takeover of Akorn , a U.S. maker of liquid generic drugs, might not be completed before ... that the rationale behin... read more


Could Data Breaches Break Up the Akorn Aquisition?

This isn’t the first time that Akorn has faced concerns regarding its security, but this could be the costliest. Essentially, Fresenius is conducting an independent investigation into “alleged breache... read more

Akorn Craters 32% On FDA Probe - Time To Buy?

The company announces a probe by Acquirer Fresenius amid FDA allegations. Akorn says it sees no material issues and the deal should ... so I am likely a daytrader in the name looking for some bounce-b... read more

Here's Why Akorn, Inc. Stock Is Getting Thrashed Today

Last April, Fresenius agreed to acquire Akorn for $34 per share, which was a steep premium to the stock's price during the weeks leading up to the announcement. As is usually the case when deals appea... read more

Why Diana Shipping, Akorn, and Granite Construction Jumped Today

But if JPMorgan is right, then a greater level of confidence in the shipping industry could lead to further gains not just for ... Already, Fresenius has made some strategic purchases within Europe, b... read more

HO UK Home Office : UK government publishes proposals on rights of EU citizens

That is why I initially sought an agreement on this before we triggered Article 50. And it is why I am making it an immediate priority at ... Those who arrived before the specified date but do not yet ... read more

Fresenius picks up M&A pace with Akorn, Merck KGaA deals

Berenberg analyst Tom Jones said the price tag of 12.4 times Akorn's core earnings (adjusted EBITDA) estimate for 2017 should not "give ... GMT (3.50 am ET), broadly in line with the European healthca... read more

The Morning Ledger: Volkswagen Prepares First U.S. Bond Sale After Emissions Scandal

Akorn pledges to fight Fresenius decision to end deal. Fresenius SE on Sunday said it is terminating ... Compensation details were not immediately available. The Morning Ledger from CFO Journal cues u... read more

Fresenius now sees completion of Akorn takeover in early 2018

FRANKFURT, Dec 19 (Reuters) - Fresenius now expects its planned takeover of Akorn, a U.S. maker of liquid generic ... The German healthcare group had already warned in November that the deal might not ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us